NHS Launches World-First 'Trojan Horse' Cancer Therapy for Blood Patients
A groundbreaking 'Trojan horse' therapy, belantamab mafodotin, has been made available on the NHS in England for treating multiple myeloma, significantly extending remission times and offering a more targeted and less harmful treatment option, marking a major advancement in cancer care.